Skip to main content
SIBN logo

SI-BONE, Inc.

SIBNNASDAQHealthcareMedical Devices

$19.91Today:- (-)1Y +31.85%

As of Oct 15, 2026 close

Market cap
$885.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.48$21.89
Volume (live)
-
Avg. volume (3M)
565.01K

SI-BONE, Inc. (SIBN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for SI-BONE, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$24.50
+23.05% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SIBN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Caitlin Roberts
Canaccord Genuity
BuyReiterates
$27.00
Matthew O'Brien
Piper Sandler
BuyReiterates
$25.00
Richard Newitter
Truist
BuyReiterates
$21.00 → $23.00
Mathew Blackman
TD Cowen
BuyReiterates
$18.00 → $20.00
Travis Steed
BofA Securities
BuyMaintains
-
Patrick Wood
UBS
BuyMaintains
$24.00 → $25.00
David Saxon
Needham
BuyReiterates
$27.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 29, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for SIBN?

The analyst consensus rating for SIBN is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for SIBN?

The average 12-month price target for SIBN is $24.50, representing an upside of 23.1% from the Oct 15, 2026 close of $19.91.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.